Trial intelligence / Profile preview

Magnesium sulfate vs dexmedetomidine vs pethidine for prevention of postoperative shivering after general anesthesia

IRCT20190606043828N1Phase 3Completed

Sponsor
Isfahan University of Medical Sciences
Start
Mar 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial of magnesium sulfate, dexmedetomidine and pethidine in postanesthetic shivering (PAS) (4 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Severity of postoperative shivering, Systolic blood pressure and 12 more. Started Mar 2017; status: completed.

02

Drugs

magnesium sulfatedexmedetomidinepethidine
03

Conditions

postanesthetic shivering (PAS)

Beyond the preview

Go deeper on IRCT20190606043828N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20190606043828N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call